BraveCX— 510(k) K223754
Substantially EquivalentBering, Ltd.
FDA 510(k) clearance K223754 for BraveCX, Substantially Equivalent on 2023-11-09. Applicant: Bering, Ltd.. Device class: 2.
Clearance details
- Applicant
- Bering, Ltd.
- Product code
- Code QFM
- Device class
- Class 2
- Regulation
- 21 CFR 892.2080
- Advisory panel
- Radiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- London, GB
Recent devices under product code QFM
view allData sourced from openFDA. This site is unofficial and independent of the FDA.